Document Detail


Treatment of Darier's disease with photodynamic therapy.
MedLine Citation:
PMID:  14510996     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Photodynamic therapy (PDT) using topical 5-aminolaevulinic acid (5-ALA) as a photosensitizer has been reported in the treatment of both neoplastic and benign cutaneous disorders. OBJECTIVES: To evaluate the efficacy of photodynamic therapy in selected patients with Darier's disease (keratosis follicularis). METHODS: Six patients with Darier's disease were assessed before and after treatment with PDT using 5-ALA and mean fluence rates of 110-150 mW cm-2. RESULTS: Of the six patients, one was unable to tolerate the treatment. Of the remaining five, all experienced an initial inflammatory response that lasted two to three weeks. In four of the five patients, this was followed by sustained clearance or improvement over a followup period of six months to three years. Three of these four patients were on systemic retinoids and the fourth had discontinued acitretin prior to PDT. In the fifth patient partial improvement was followed by recurrence after etretinate therapy was discontinued. Biopsy specimens taken immediately after the procedure in two patients demonstrated a mild inflammatory cell infiltrate in the dermis. A biopsy obtained eighteen months after PDT from a successfully treated area showed no signs of Darier's disease and a subtle increase of collagen in the upper dermis. CONCLUSIONS: Photodynamic therapy can be viewed as a potential adjunctive modality for Darier's disease but should not be considered as a substitute for retinoids in patients who require systemic treatment.
Authors:
D Exadaktylou; H A Kurwa; E Calonje; R J Barlow
Related Documents :
10570376 - Medium-dose uva1 cold-light phototherapy in the treatment of severe atopic dermatitis.
15996416 - Long-term clinical outcomes following treatment of actinic keratosis with imiquimod 5% ...
15552596 - Combination therapy for solar lentigines.
17178496 - A random clinical trial study to assess the efficiency of topical applications of podop...
2415896 - Krypton red laser photocoagulation for subretinal neovascularization.
7794776 - Dapsone for refractory chronic idiopathic thrombocytopenic purpura.
Publication Detail:
Type:  Evaluation Studies; Journal Article    
Journal Detail:
Title:  The British journal of dermatology     Volume:  149     ISSN:  0007-0963     ISO Abbreviation:  Br. J. Dermatol.     Publication Date:  2003 Sep 
Date Detail:
Created Date:  2003-09-26     Completed Date:  2003-12-18     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0004041     Medline TA:  Br J Dermatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  606-10     Citation Subset:  IM    
Affiliation:
Department of Histopathology, St John's Institute of Dermatology, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK. despgr@doctors.org.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aminolevulinic Acid / therapeutic use*
Darier Disease / drug therapy*
Female
Humans
Male
Middle Aged
Photochemotherapy / methods*
Photosensitizing Agents / therapeutic use*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Photosensitizing Agents; 106-60-5/Aminolevulinic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan-l...
Next Document:  Improved risk-benefit ratio for topical triamcinolone acetonide in Transfersome in comparison with e...